Table 3 Intronic variant which is affected splicing within 11–50 bp from exon.

From: Identifying pathogenic variants in rare pediatric neurological diseases using exome sequencing

ID

HPO term

M-PMS

chr

Position

ref

alt

Inheritance

Gene, variant

SpliceAI delta score AG|AL|DG|DL

ClinVar (# of submissions)

17132

HP:0000113;HP:0002023;HP:0001249;HP:0001320;HP:0002282

0.714

10

1,103,570

TCTT

de novo

WDR37

NM_014023.4:c.727 − 27_727-24del, p.(Ser246_Glu247insLeuCysGlnLysLysLeuLysIleSerArgLysCysLeuPheTrpProSerLeuTrpGlnGln)

0.44|0.14|0.01|0.01

Likely_pathogenic (1)

20065

HP:0006855

2.055

12

88,068,657

A

T

Paternal

CEP290

NM_025114.4:c.6012-12T > A

0.34|0.95|0.01|0.04

Pathogenic (2)

21038

HP:0001274;HP:0000365;HP:0002119

1.528

X

153,869,687

A

C

Maternal

L1CAM

NM_001278116.2:c.1124-24T > G

0.99|0.18|0.00|0.00

 

21118

HP:0002119;HP:0001172

2.019

X

153,863,391

C

T

de novo

L1CAM

NM_001278116.2:c.3531-12G > A

0.97|0.65|0.04|0.00

Pathogenic (2)

  1. M-PMS, Maximum PhenoMatch score; AG, Acceptor gain; AL, Acceptor loss; DG, Donor gain; DL, Donor loss.